Original Research

Frequency of UTI in Diabetic Patients taking SGLT2 Inhibitors

Aisha Aziz
Arif Memorial Teaching Hospital, Rashid Latif Medical College Lahore
Asma Kazi
Arif Memorial Teaching Hospital, Rashid Latif Medical College Lahore
Ammara Asim
Arif Memorial Teaching Hospital, Rashid Latif Medical College Lahore
Rahman Javed
Arif Memorial Teaching Hospital, Rashid Latif Medical College Lahore
Faisal Zarar
Arif Memorial Teaching Hospital, Rashid Latif Medical College Lahore
Faaiqa Saqlain
Arif Memorial Teaching Hospital, Rashid Latif Medical College Lahore

✉ Correspondence: Asma Kazi Email: docasmakazi@gmail.com

DOI https://doi.org/10.70302/jpsim.v5i1.2404
Volume: 5, Issue 1 (Women Issue) Pages: 375–378 Published: 28 Feb 2024
Received: 22 Sep 2023 Accepted: 10 Dec 2023 Published Online: 28 Feb 2024

Abstract

Objective

The objective of this study is to evaluate the frequency of UTI in diabetic patients taking SGLT2 inhibitors.

Methods

It was a cross-sectional study in which 125 diabetic patients from Arif Memorial Teaching Hospital, Lahore were enrolled. Data was gathered from individuals with Type 2 diabetes who were undergoing treatment with SGLT2i, either as monotherapy or in combination with other medications, over a span of three months. Data was entered and analyzed through computer software SPSS version 25.0.

Results

Among 125 diabetic patients, 45.6 were males and 54.4% were females and the mean age was 46.19+8.718 years. Association of UTI with age was found statistically significant while association of UTI with gender, family history of diabetes, duration of diabetes and SGLT2 inhibitors was found statistically insignificant.

Conclusion

Study concluded that frequency of UTI among diabetic patients taking SGLT2i was 8.8%.

Keywords
: Frequency urinary tract infection diabetes SGLT2 inhibitors

How to Cite This Article

Aziz A, Kazi A, Asim A, Javed R, Zarar F, Saqlain F. Frequency of UTI in Diabetic Patients taking SGLT2 Inhibitors. J Pak Soc Intern Med. 2024;5(1):375–378. doi:10.70302/jpsim.v5i1.2404

⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. Alsifri S, Almaghamsi AM, Mahfouz AS, Shehab-Eldin W, Rakha S. Safety of empagliflozin in patients with type 2 diabetes mellitus in Saudi Arabia: a post-authorisation safety study. Int J Clin Med. 2023;14(3): 129-47.
  2. Alam A, Akbar S, Khan IA, Gul R, Rehman R, Noreen S. Risk factors assessment of type 2 diabetes mellitus in adult male population of Hayatabad, Peshawar: a cross-sectional study. Khyber J Med Sci. 2021; 14(1): 13-7.
  3. Azeem S, Khan U, Liaquat A. The increasing rate of diabetes in Pakistan: a silent killer. Ann Med Surg (Lond). 2022; doi: 10.1016/j.amsu.2022. 103901 doi:10.1016/j.amsu.2022
  4. Azhar M, Hanif M, Rafi S, Ziauddin M, Sohail N, Kumar R. Frequency of urinary tract infections in type 2 diabetes patients taking sodium-glucose cotransporter-2 (SGLT2) inhibitors to regulate their blood sugar level. J Pharm Neg Results. 2023; 14(4): 95-99.
  5. Khan S, Hashmi MS, Rana MA, Zafar GM, Asif S, Farooq MT, et al. Frequency of urinary tract infections in type 2 diabetic patients taking dapagliflozin. Cureus. 2022; 14(1): e21720.
  6. Hussain M, Hussain A, Rehman HU, Iqbal J. Prevalence of genitourinary infections with sodium glucose cotransporter-2 (SGLT2) inhibitors in patients with type 2 diabetes. Pak J Med Health Sci. 2021; 15(10): 2804-7.
  7. Ferwani P, Maldar A, Shah N, Chauhan P, Chadha M. Prevalence of bacterial urinary tract infection among patients with type 2 diabetes mellitus on sodium-glucose cotransporter-2 inhibitors: a prospective real-world setting study. J ASEAN Fed Endocr Soc. 2022; 37(2): 5-8.
  8. Ashfaq M, Shafique S, Niazi Z, Shah SY, Memon S, Qureshi K, et al. Occurrence of urinary tract infections in type 2 diabetes mellitus patients taking sodium-glucose co-transporter-2 (SGLT-2) inhibitors to regulate their blood sugar levels. Int J Health Sci. 2023; 7(S1): 1947-53.
  9. Shrikrishna A, Archana B. Prevalence of genitourinary infection in diabetic patients treated with SGLT 2 inhibitors. Afri Health Sci. 2023; 23(1): 270-5.
  10. Bapir R, Bhatti KH, Eliwa A, García-Perdomo HA, Gherabi N, Hennessey D, et al. Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis. Arch Italiano Urolog Androlog. 2023; doi: 10.4081/ aiua.2023.11509
  11. Caro MKC, Cunanan EC, Kho SA. Incidence and factors associated with genitourinary infections among Type 2 diabetes patients on SGLT2 Inhibitors: a single retrospective cohort study. Diabetes Epidemiol Manag. 2022; doi: 10.1016/j.deman.2022. 100082 doi:10.1016/j.deman.2022
  12. Yang H, Choi E, Park E, Na E, Chung SY, Kim B, et al. Risk of genital and urinary tract infections associated with SGLT-2 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes mellitus: A retrospective cohort study in Korea. Pharmacol Res Perspect. 2022; doi: 10.1002/prp2.910 doi:10.1002/prp2.910
  13. Liu J, Li L, Li S, Jia P, Deng K, Chen W, et al. Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis. Sci Rep. 2017; doi: 10.1038/s41598-017-02733-w doi:10.1038/s41598-017-02733-w
  14. Sarafidis PA, Ortiz A. The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern? Clin Kidney J. 2020; 13(1): 24-6.
  15. Figueiredo IR, Rose SCP, Freire NB, Patrocínio MS, Pierdoná N, Bittencourt RJ. Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: a systematic review. Rev Assoc Med Bras. 2019; 65(2): 246-52.
  16. Min SH, Yoon JH, Moon SJ, Hahn S, Cho YM. Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis. Sci Rep. 2018; 8(1): 4466.
  17. Puckrin R, Saltiel MP, Reynier P, Azoulay L, Yu OHY, Filion KB. SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials. Acta Diabetol. 2018; 55(5): 503-14.
  18. Donnan JR, Grandy CA, Chibrikov E, Marra CA, Aubrey-Bassler K, Johnston K, et al. Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis. BMJ Open. 2019; 9(1): e022577.
  19. Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MW, et al. Sodium-glucose cotransporter-2 inhibitors and urinary tract infections: a propensity score–matched population-based cohort study. Can J Diabetes. 2022; 46(4): 392-403.
  20. Uitrakul S, Aksonnam K, Srivichai P, Wicheannarat S, Incomenoy S. The incidence and risk factors of urinary tract infection in patients with type 2 diabetes mellitus using SGLT2 inhibitors: a real-world observational study. Medicines. 2022; 9(12): 59. DOI: 10.3390/medicin es9120059 doi:10.3390/medicin

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2024 Journal of Pakistan Society of Internal Medicine.
📃 In This Issue View All
Original Article Prevalence of Hypertension Among Urban Adults in Pakistan: A Cross-Sectional Study Khan TM, Ahmed S, Malik RA Review Article Antibiotic Resistance Patterns in Community-Acquired Pneumonia: Emerging Trends Hussain I, Farooq Z Original Article Comparison of Ultrasound-Guided versus Landmark-Based Central Venous Catheter Insertion Zafar S, Gillani SA Review Article Statin Therapy in Non-Alcoholic Fatty Liver Disease: A Systematic Review Nawaz F, Cheema HA, Mehmood Y Original Article Outcomes of Laparoscopic Cholecystectomy in Acute Cholecystitis: A Retrospective Analysis Raza SH, Butt N, Qureshi AM
👥 More by These Authors
Original Article Impact of Diabetes Mellitus on Post-Operative Wound Healing in General Surgery Siddiqui FA, Noor M, Akhtar W Original Article Cervical Cancer Screening Awareness Among Rural Women in Punjab Bibi S, Anjum R, Hassan F Review Article Thyroid Disorders in Pregnancy: Clinical Implications and Management Strategies Baig BI, Usman A Original Article Serum Ferritin as a Prognostic Marker in COVID-19 Severity: A Hospital-Based Study Rehman N, Sheikh I, Javed K
🔗 Related Articles By Keywords
Original Article Comparison of Ultrasound-Guided versus Landmark-Based Central Venous Catheter Insertion Zafar S, Gillani SA Review Article Statin Therapy in Non-Alcoholic Fatty Liver Disease: A Systematic Review Nawaz F, Cheema HA, Mehmood Y Original Article Outcomes of Laparoscopic Cholecystectomy in Acute Cholecystitis: A Retrospective Analysis Raza SH, Butt N, Qureshi AM Original Article Neonatal Sepsis: Bacteriological Profile and Antibiogram in a Tertiary Care Hospital Iqbal M, Rashid T